Sec. 712. Reauthorization of the critical path public-private partnership program
40 words·~1 min read·
/bill/117/hr/7667/eh/section-712A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 566(f) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–5(f) ) is amended by striking $6,000,000 for each of fiscal years 2018 through 2022 and inserting $10,000,000 for each of fiscal years 2023 through 2027 .
Connections1 off-index
1 reference not yet in our index
- 21 USC 360bbb–5(f)
Citation graph
cites case law
Sec. 712
Reauthorization of the critical path public-private partnership program
Cite21 USC 360bbb–5(f)
Cites 1Cited by 0 across 0 sources